ERBB2 and glioblastoma: Further analysis identified specific pathways that are most altered, including many that have been previously implicated in GBM [13] such as ERBB2 signaling (p < 8 × 10-8), and TNF-alpha and FAS signaling (p < 7 × 10-8).